Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | STOXX® Europe 600 Health Care |
| Investment focus | Equity, Europe, Health Care |
| Fund size | EUR 747 m |
| Total expense ratio | 0.46% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 18.06% |
| Inception/ Listing Date | 25 April 2001 |
| Distribution policy | Distributing |
| Distribution frequency | At least annually |
| Fund domicile | Germany |
| Fund Provider | iShares |
| Fund Structure | Contractual Fund |
| UCITS compliance | Yes |
| Administrator | State Street Bank International GmbH |
| Investment Advisor | |
| Custodian Bank | State Street Bank International GmbH |
| Revision Company | Deloitte |
| Fiscal Year End | 1 March |
| Swiss representative | BlackRock Asset Management Schweiz AG |
| Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| AstraZeneca PLC | 13.93% |
| Novartis AG | 12.92% |
| Roche Holding AG | 12.49% |
| Novo Nordisk A/S | 8.75% |
| Sanofi | 6.32% |
| EssilorLuxottica SA | 6.30% |
| GSK Plc | 5.20% |
| argenx | 2.71% |
| Lonza Group AG | 2.66% |
| Haleon | 2.26% |
| Switzerland | 31.74% |
| United Kingdom | 22.75% |
| France | 13.87% |
| Germany | 5.88% |
| Other | 25.76% |
| Health Care | 77.01% |
| Consumer Discretionary | 6.30% |
| Consumer Staples | 2.26% |
| Basic Materials | 1.15% |
| Other | 13.28% |
| YTD | +3.27% |
| 1 month | +4.98% |
| 3 months | +7.18% |
| 6 months | +15.62% |
| 1 year | +9.31% |
| 3 years | +20.92% |
| 5 years | +46.16% |
| Since inception (MAX) | +313.91% |
| 2025 | +7.16% |
| 2024 | +3.86% |
| 2023 | +8.11% |
| 2022 | -6.69% |
| Current dividend yield | 1.53% |
| Dividends (last 12 months) | EUR 1.80 |
| Period | Dividend in EUR | Dividend yield in % |
|---|---|---|
| 1 Year | EUR 1.80 | 1.64% |
| 2025 | EUR 1.80 | 1.66% |
| 2024 | EUR 1.57 | 1.49% |
| 2023 | EUR 1.69 | 1.70% |
| 2022 | EUR 1.59 | 1.47% |
| Volatility 1 year | 18.06% |
| Volatility 3 years | 14.77% |
| Volatility 5 years | 14.64% |
| Return per risk 1 year | 0.52 |
| Return per risk 3 years | 0.44 |
| Return per risk 5 years | 0.54 |
| Maximum drawdown 1 year | -21.34% |
| Maximum drawdown 3 years | -26.42% |
| Maximum drawdown 5 years | -26.42% |
| Maximum drawdown since inception | -48.46% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | EXV4 | - - | - - | - |
| Stuttgart Stock Exchange | EUR | EXV4 | - - | - - | - |
| SIX Swiss Exchange | EUR | SXDPEX | SXDPEX SE SXDPNAV | SXDPEX.S RXPXNAV.DE | |
| XETRA | EUR | EXV4 | SXDPEX GY SXDPNAV | SXDPEX.DE RXPXNAV.DE |